Spearheading CRISPR/Cas9 Screening to Identity Genes Necessary for LSD1 to Maintain the Neuroendocrine Identify of Small Cell Lung Cancer

Time: 3:15 pm
day: Day One


  • Leveraging genome-wide CRISPR/Cas9 screening to identify key targets of LSD1
  • Identifying key regulators of neuroendocrine cell state
  • Highlighting cell state plasticity to unmask immunogenicity